HDAC8 inhibition ameliorates pulmonary fibrosis
Shigeki Saito(Tokyo Metropolitan University), Joseph A. Lasky(Tulane University)
American Journal of Physiology-Lung Cellular and Molecular Physiology
October 25, 2018
Cited by 67
Related Papers
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
|The Lancet Respiratory Medicine|2022|211
Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
|Journal of Biological Chemistry|2008|171